Rapid Micro Biosystems, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Rapid Micro Biosystems, Inc. | RPID - NASDAQ |
$18.00-$20.00 | $20.00 | $22.50 | 7.9 million | 7/15/2021 |
| JP Morgan, Morgan Stanley, Cowen, Stifel | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-06-25 Terms Added 2021-07-12 | ||||||
Rapid Micro Biosystems, Inc. Quote & Chart - Click for current quote - RPID
IPO Boutique aggregates information on public companies and private companies, such as "RPID" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Rapid Micro Biosystems, Inc. (adapted from Rapid Micro Biosystems, Inc. prospectus):
They are an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "RPID" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.